Dr. Ashok Srivastava, MD, Ph.D., MBA

Medical Oncologist and Hematologist, 

CAR-T Cell Therapy and Oncolytic Virus Therapy of Metastatic Breast and Brain Cancers

Attends and Chair the sessions- The 4th Congress of Biopharma Industry Development 2025, Shanghai, China

 

https://www.gala-tech.cn/bioexpo2025en/default.asp

Conquers Cancer

Dr. Ashok Srivastava, MD, Ph.D., MBA, attended ASCO-2024, Chicago; www.asco.org

Our Professional Partner

Sun-Logo

Transtherapeutic is rated; Best Consulting Company For Oncology Drug Launch

home_hosting_slide_1_3.png
http://www.usatvnews.org/clinfomatrix-best-consulting-company-oncology-drug-launch/
home_hosting_slide_1_3.png
http://www.usatvnews.org/category/press-release/page/2/

Dr. Ashok Srivastava

Dr. Ashok Srivastava will attend the Cancer and Oncology Research, May 30-31, 2024 Rome, Italy as Invited Speaker and he will Chair the Sessions.

homepic2

Core Competencies

null

Clinical Medical
Strategy

Clinical Medical
Strategy

Read More
right2

Clinical Trial
Execution

Clinical Trial
Execution

Read More
null

Clinical
Trial

Clinical
Trial

Read More
right2

Clinical Safety Pharmacovigilance

Clinical Safety Pharmacovigilance

Read More
right2

Medical
Monitoring

Medical
Monitoring

Read More
null

Medical, Clinical and Regulatory support

Medical, Clinical and Regulatory support

Read More
right2

Professional Resource
Service

Professional Resource
Service

Read More
null

Strategic
Consulting

Strategic
Consulting

Read More